BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21613802)

  • 21. FHIT alterations in cancerous and non-cancerous cervical epithelium.
    Yoshino K; Enomoto T; Nakamura T; Sun H; Ozaki K; Nakashima R; Wada H; Saitoh J; Watanabe Y; Noda K; Murata Y
    Int J Cancer; 2000 Jan; 85(1):6-13. PubMed ID: 10585575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer.
    Zhang HR; Lai SY; Huang LJ; Zhang ZF; Liu J; Zheng SR; Ding K; Bai X; Zhou JY
    Gynecol Oncol; 2018 Apr; 149(1):188-197. PubMed ID: 29395313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin and prolactin receptor expression in cervical intraepithelial neoplasia and cancer.
    Ascencio-Cedillo R; López-Pulido EI; Muñoz-Valle JF; Villegas-Sepúlveda N; Del Toro-Arreola S; Estrada-Chávez C; Daneri-Navarro A; Franco-Topete R; Pérez-Montiel D; García-Carrancá A; Pereira-Suárez AL
    Pathol Oncol Res; 2015 Apr; 21(2):241-6. PubMed ID: 24990775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma.
    Kauttu T; Mustonen H; Vainionpää S; Krogerus L; Ilonen I; Räsänen J; Salo J; Puolakkainen P
    Clin Transl Oncol; 2017 Jan; 19(1):58-66. PubMed ID: 27026568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix.
    Zubel A; Flechtenmacher C; Edler L; Alonso A
    Gynecol Oncol; 2009 Aug; 114(2):332-6. PubMed ID: 19473694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunolabeling of the inhibin-βA and -βB subunit in normal and malignant human cervical tissue and cervical cancer cell lines.
    Jückstock J; Brüning A; Blankenstein T; Kunze S; Shabani N; Bergauer F; Mylonas I
    Int J Gynecol Cancer; 2010 Oct; 20(7):1117-24. PubMed ID: 21475087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.
    Connolly DC; Greenspan DL; Wu R; Ren X; Dunn RL; Shah KV; Jones RW; Bosch FX; Muñoz N; Cho KR
    Clin Cancer Res; 2000 Sep; 6(9):3505-10. PubMed ID: 10999736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The significance of K-Cl cotransport1 expression in cervical cancer tissues].
    Lu XY; Zhang SL; Lu YM; Xiu XX; Sun XW
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(17):1156-9. PubMed ID: 17686231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases.
    Schwettmann L; Wehmeier M; Jokovic D; Aleksandrova K; Brand K; Manns MP; Lichtinghagen R; Bahr MJ
    J Hepatol; 2008 Aug; 49(2):243-50. PubMed ID: 18490073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OCT-4 and DAZL expression in precancerous lesions of the human uterine cervix.
    Stefanidis K; Pergialiotis V; Christakis D; Patta J; Stefanidi D; Loutradis D
    J Obstet Gynaecol Res; 2015 May; 41(5):763-7. PubMed ID: 25491317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10.
    Schelter F; Grandl M; Seubert B; Schaten S; Hauser S; Gerg M; Boccaccio C; Comoglio P; Krüger A
    Clin Exp Metastasis; 2011 Dec; 28(8):793-802. PubMed ID: 21789719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADAM-17 expression in breast cancer correlates with variables of tumor progression.
    McGowan PM; Ryan BM; Hill AD; McDermott E; O'Higgins N; Duffy MJ
    Clin Cancer Res; 2007 Apr; 13(8):2335-43. PubMed ID: 17438092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer.
    de Wilde J; Wilting SM; Meijer CJ; van de Wiel MA; Ylstra B; Snijders PJ; Steenbergen RD
    Int J Cancer; 2008 Feb; 122(4):877-88. PubMed ID: 17960611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical expression of DNA mismatch repair (MMR) system proteins (hMLH1, hMSH2) in cervical preinvasive and invasive lesions.
    Ciavattini A; Piccioni M; Tranquilli AL; Filosa A; Pieramici T; Goteri G
    Pathol Res Pract; 2005; 201(1):21-5. PubMed ID: 15807307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of MIF, VEGF and p16 proteins and their correlation with clinicopathological features in cervical cancer].
    Li W; He M; Zeng JF; Xia JT; Chen LZ; Chen Y; Liu JX
    Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):511-4. PubMed ID: 19062717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interaction between abnormal expression of fragile histidine triad and methyl-CpG-binding protein 2 on cervical cancerization].
    Yang Q; Li Y; Wang L; Song ZC; Feng MJ; Ding L; Wang JT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):689-693. PubMed ID: 29860820
    [No Abstract]   [Full Text] [Related]  

  • 37. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
    Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
    Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression and clinical significance of Pin1 and Cyclin D1 in cervical cancer cell lines and cervical epithelial tissues].
    Li HY; Xu Q; Zhu T; Zhou JH; Deng DR; Wang SX; Lu YP; Ma D
    Ai Zheng; 2006 Mar; 25(3):367-72. PubMed ID: 16536997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri.
    Klaes R; Friedrich T; Spitkovsky D; Ridder R; Rudy W; Petry U; Dallenbach-Hellweg G; Schmidt D; von Knebel Doeberitz M
    Int J Cancer; 2001 Apr; 92(2):276-84. PubMed ID: 11291057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue inhibitor of metalloproteinases-4 (TIMP-4) regulates stemness in cervical cancer cells.
    Lizarraga F; Espinosa M; Ceballos-Cancino G; Vazquez-Santillan K; Bahena-Ocampo I; Schwarz-Cruz Y Celis A; Vega-Gordillo M; Garcia Lopez P; Maldonado V; Melendez-Zajgla J
    Mol Carcinog; 2016 Dec; 55(12):1952-1961. PubMed ID: 26618609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.